Abstract
The miniature CRISPR-Cas12f nucleases enable efficient delivery via cargo-size-limited vehicles, thereby showing promise for in vivo therapeutic applications. Acidibacillus sulfuroxidans Cas12f1 (AsCas12f1, 422 amino acids) is one of the most compact Cas12f nucleases and exhibits moderate genome-editing activity in human cells compared with Cas9 and Cas12a. Understanding the mechanisms of why such a compact nuclease is active for genome editing would facilitate its rational engineering. Here we show the cryo-electron microscopy structure of the AsCas12f1–sgRNA–dsDNA ternary complex, and reveal that AsCas12f1 functions as an asymmetric dimer for sgRNA binding and DNA targeting. The mechanisms of dimer formation, protospacer adjacent motif recognition and sgRNA accommodation are elucidated. Based on these findings, we extensively engineer this system and have produced an evolved AsCas12f1–sgRNA combination with drastically enhanced genome-editing activity in human cells. These results provide further understanding of compact CRISPR systems and expand the mini CRISPR toolbox for therapeutic applications.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
The structure of AsCas12f1 in complex with sgRNA and target DNA has been deposited in the Protein Data Bank under the accession code 7WJU, and in the EMDB under the accession code EMD-32548. All other data are available from the corresponding authors. Source data are provided with this paper.
Code availability
The sequencing data for evaluating indel efficiencies are demultiplexed by using barcodeSpliter (https://github.com/atlasbioinfo/barcodeSpliter). The indel efficiencies are evaluated by using the CRISPResso2 suite which is available at GitHub (https://github.com/pinellolab/CRISPResso2). The computational pipeline for GUIDE-seq is available at GitHub (https://github.com/aryeelab/guideseq).
References
Makarova, K. S. et al. Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Nat. Rev. Microbiol. 18, 67–83 (2020).
Wang, J. Y., Pausch, P. & Doudna, J. A. Structural biology of CRISPR-Cas immunity and genome editing enzymes. Nat. Rev. Microbiol. 20, 641–656 (2022).
Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).
Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759–771 (2015).
Li, G. et al. Gene editing and its applications in biomedicine. Sci. China Life. Sci. 65, 660–700 (2022).
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424 (2016).
Nishida, K. et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science 353, aaf8729 (2016).
Gaudelli, N. M. et al. Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature 551, 464–471 (2017).
Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149–157 (2019).
Wu, Z. et al. Strategies for developing CRISPR-based gene editing methods in bacteria. Small Methods 4, 1900560 (2020).
Zhu, H., Li, C. & Gao, C. Applications of CRISPR-Cas in agriculture and plant biotechnology. Nat. Rev. Mol. Cell Biol. 21, 661–677 (2020).
Gillmore, J. D. et al. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493–502 (2021).
Raje, N. et al. Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma. N. Engl. J. Med. 380, 1726–1737 (2019).
Yin, D. et al. Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice. Nat. Biotechnol. 39, 567–577 (2021).
Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 18, 358–378 (2019).
Liu, J. J. et al. CasX enzymes comprise a distinct family of RNA-guided genome editors. Nature 566, 218–223 (2019).
Wu, Z. et al. Programmed genome editing by a miniature CRISPR-Cas12f nuclease. Nat. Chem. Biol. 17, 1132–1138 (2021).
Karvelis, T. et al. PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage. Nucleic Acids Res. 48, 5016–5023 (2020).
Takeda, S. N. et al. Structure of the miniature type V-F CRISPR-Cas effector enzyme. Mol. Cell 81, 558–570.e553 (2021).
Xiao, R., Li, Z., Wang, S., Han, R. & Chang, L. Structural basis for substrate recognition and cleavage by the dimerization-dependent CRISPR-Cas12f nuclease. Nucleic Acids Res. 49, 4120–4128 (2021).
Yan, W. X. et al. Functionally diverse type V CRISPR-Cas systems. Science 363, 88–91 (2019).
Zhang, H., Li, Z., Xiao, R. & Chang, L. Mechanisms for target recognition and cleavage by the Cas12i RNA-guided endonuclease. Nat. Struct. Mol. Biol. 27, 1069–1076 (2020).
Huang, X. et al. Structural basis for two metal-ion catalysis of DNA cleavage by Cas12i2. Nat. Commun. 11, 5241 (2020).
Zhang, B. et al. Mechanistic insights into the R-loop formation and cleavage in CRISPR-Cas12i1. Nat. Commun. 12, 3476 (2021).
Pausch, P. et al. CRISPR-CasΦ from huge phages is a hypercompact genome editor. Science 369, 333–337 (2020).
Pausch, P. et al. DNA interference states of the hypercompact CRISPR-CasΦ effector. Nat. Struct. Mol. Biol. 28, 652–661 (2021).
Carabias, A. et al. Structure of the mini-RNA-guided endonuclease CRISPR-Cas12j3. Nat. Commun. 12, 4476 (2021).
Sun, A. et al. The compact Casπ (Cas12l) ‘bracelet’ provides a unique structural platform for DNA manipulation. Cell Res. 33, 229–244 (2023).
Al-Shayeb, B. et al. Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors. Cell 185, 4574–4586.e4516 (2022).
Karvelis, T. et al. Transposon-associated TnpB is a programmable RNA-guided DNA endonuclease. Nature 599, 692–696 (2021).
Altae-Tran, H. et al. The widespread IS200/IS605 transposon family encodes diverse programmable RNA-guided endonucleases. Science 374, 57–65 (2021).
Schuler, G., Hu, C. & Ke, A. Structural basis for RNA-guided DNA cleavage by IscB-ωRNA and mechanistic comparison with Cas9. Science 376, 1476–1481 (2022).
Karvelis, T. et al. PAM recognition by miniature CRISPR nucleases triggers programmable double-stranded DNA target cleavage. Preprint at https://www.biorxiv.org/content/10.1101/654897v1 (2020).
Bigelyte, G. et al. Miniature type V-F CRISPR-Cas nucleases enable targeted DNA modification in cells. Nat. Commun. 12, 6191 (2021).
Zhang, H. et al. An engineered xCas12i with high activity, high specificity, and broad PAM range. Protein Cell https://doi.org/10.1093/procel/pwac052 (2022).
Xu, X. et al. Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing. Mol. Cell 81, 4333–4345.e4334 (2021).
Kim, D. Y. et al. Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus. Nat. Biotechnol. 40, 94–102 (2021).
Tsuchida, C. A. et al. Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity. Mol. Cell 82, 1199–1209.e1196 (2022).
McGaw, C. et al. Engineered Cas12i2 is a versatile high-efficiency platform for therapeutic genome editing. Nat. Commun. 13, 2833 (2022).
Chen, Y. et al. Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing. Innovation 3, 100264 (2022).
Harrington, L. B. et al. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science 362, 839–842 (2018).
Nakagawa, R. et al. Cryo-EM structure of the transposon-associated TnpB enzyme. Nature, https://doi.org/10.1038/s41586-023-05933-9 (2023).
Sasnauskas, G. et al. TnpB structure reveals minimal functional core of Cas12 nuclease family. Nature, https://doi.org/10.1038/s41586-023-05826-x (2023).
Yang, H., Gao, P., Rajashankar, K. R. & Patel, D. J. PAM-dependent target DNA recognition and cleavage by C2c1 CRISPR-Cas endonuclease. Cell 167, 1814–1828.e1812 (2016).
Yamano, T. et al. Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell 165, 949–962 (2016).
Huang, H. et al. Comparison of DNA targeting CRISPR editors in human cells. Cell Biosci. 13, 11 (2023).
Tsai, S. Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187–197 (2015).
Xin, C. et al. Comprehensive assessment of miniature CRISPR-Cas12f nucleases for gene disruption. Nat. Commun. 13, 5623 (2022).
Lei, J. & Frank, J. Automated acquisition of cryo-electron micrographs for single particle reconstruction on an FEI Tecnai electron microscope. J. Struct. Biol. 150, 69–80 (2005).
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
Grant, T. & Grigorieff, N. Measuring the optimal exposure for single particle cryo-EM using a 2.6 Å reconstruction of rotavirus VP6. Elife 4, e06980 (2015).
Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016).
Chen, S. et al. High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy 135, 24–35 (2013).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214–1221 (2020).
Rosenthal, P. B. & Henderson, R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333, 721–745 (2003).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531–544 (2018).
Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772–780 (2013).
Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol. Biol. Evol. 26, 1641–1650 (2009).
Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 49, W293–W296 (2021).
Zhang, Y. et al. Programmable adenine deamination in bacteria using a Cas9-adenine-deaminase fusion. Chem. Sci. 11, 1657–1664 (2020).
Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224–226 (2019).
Acknowledgements
This work was supported by grants 2022YFC3400200 from the National Key R&D Program of China; LG-QS-202206-05 from the Lingang Laboratory; 22277078, 2207783 and 22207074 from the National Natural Science Foundation of China; 22ZR1480100 and 22YF1428100 from the Shanghai Committee of Science and Technology, China; KF-202303 from the Open Research Fund of the National Center for Protein Sciences at Peking University in Beijing; and EKPG21-18 from the Emergency Key Program of Guangzhou Laboratory. The authors also thank the Analytical Instrumentation Center, SPST, ShanghaiTech University for technical support with the ICP-OES.
Author information
Authors and Affiliations
Contributions
Z. Wu and Q.J. conceived the initial study. Z. Wu, D.L., Z.Z., Y.Q. and H.S. determined the structure of the AsCas12f1 effector complex. Z. Wu, D.P., J.S., J.M., W.F., Z. Wang, F.L. and W.C. performed plasmid construction, protein purification and biochemical experiments. Z. Wu, D.P., J.S., J.M., W.F. and H.Y. performed the genome editing in human cells and NGS data analyses. Z. Wu, D.P., D.L., X.H., H.S. and Q.J analysed and discussed the experimental data. Z. Wu and Q.J. prepared the figures and wrote the paper. The paper was reviewed and approved by all coauthors.
Corresponding authors
Ethics declarations
Competing interests
Q.J., Zhaowei Wu and D.P. have filed a patent application (PCT/CN2022/113357) related to this work through ShanghaiTech University. The remaining authors declare no competing interest.
Peer review
Peer review information
Nature Catalysis thanks Feng Gu, Ervin Welker, and Ning Jia for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Table 1 and Supplementary Figs. 1-13.
Supplementary Data 1 and 2
Information for DNA and RNA sequences used in this study.
Supplementary Data 3
Statistical source data and unmodified gel images for Supplementary Figures.
Source data
Source Data Figs. 3–7
Statistical source data for Figs. 3c, 4d, 5e,f, 6a,c,d and 7.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wu, Z., Liu, D., Pan, D. et al. Structure and engineering of miniature Acidibacillus sulfuroxidans Cas12f1. Nat Catal 6, 695–709 (2023). https://doi.org/10.1038/s41929-023-00995-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41929-023-00995-4
This article is cited by
-
Targeted mutagenesis in mice via an engineered AsCas12f1 system
Cellular and Molecular Life Sciences (2024)